Literature DB >> 6632940

Modern thirty-day operative mortality for surgical resections in lung cancer.

R J Ginsberg, L D Hill, R T Eagan, P Thomas, C F Mountain, J Deslauriers, W A Fry, R O Butz, M Goldberg, P F Waters.   

Abstract

Modern postoperative mortality rates for resectional operations for lung cancer are not readily available. In recent publications estimating the risk factors for surgical resection, mortality rates of 10% to 15% for pneumonectomy and 5% to 7% for lobectomy are frequently quoted. In order to determine modern operative mortality rates (up to 30 days postoperatively), the Lung Cancer Study Group (LCSG) analyzed the surgical mortality rates of the various participating centers during the years 1979 to 1981. A total of 2,200 resections for lung cancer were available for analysis. Of the 2,220 resections performed, 1,058 were lobectomies, 569 were pneumonectomies, and 143 were lesser resections (segmental or wedge). Eighty-one postoperative deaths occurred from among the 2,220 resections (3.7%). The mortality rate for pneumonectomy was 6.2% and for lobectomy, 2.9%. Lesser resections carried a 1.4% mortality rate, not statistically different from lobectomy. In patients under the age of 60 years, the mortality rate was 1.3%, 60 to 69 years, 4.1%, and over 70 years, 7.1%, all significantly different (p less than 0.01). The postoperative mortality rate for patients 70 years or older was 7.1% (pneumonectomy 5.9% and lobectomy 7.3%). It is obvious that greater care was taken in selection among the older pneumonectomy patients. The striking similarity of postoperative mortality rates for resectional operations for lung cancer among the various centers of the LCSG and among the various institutions within these centers suggest that these data are a reasonably accurate analysis of modern surgical mortality rates in the treatment of lung cancer.

Entities:  

Mesh:

Year:  1983        PMID: 6632940

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  69 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 2.  18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.

Authors:  G Laking; P Price
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Predicting length of stay out of hospital following lung resection using preoperative health status measures.

Authors:  Janet A Parsons; Michael R Johnston; Arthur S Slutsky
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

4.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

5.  Initial clinical outcomes after completion of training in a Canadian Royal College thoracic surgery program.

Authors:  Steven Milman; Thomas Ng
Journal:  Can J Surg       Date:  2006-12       Impact factor: 2.089

6.  Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients.

Authors:  Mark W Onaitis; Rebecca P Petersen; Stafford S Balderson; Eric Toloza; William R Burfeind; David H Harpole; Thomas A D'Amico
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

Review 7.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

Authors:  D J Sugarbaker; J P Garcia; W G Richards; D H Harpole; E Healy-Baldini; M M DeCamp; S J Mentzer; M J Liptay; G M Strauss; S J Swanson
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

9.  [Completion pneumonectomy. Indications and results].

Authors:  W Jungraithmayr; J Hasse; M Olschewski; E Stoelben
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

10.  Staging and management of lung cancer: sleeve resection.

Authors:  J Deslauriers; R J Mehran; C Guimont; J Brisson
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.